TVTX
Travere Therapeutics·NASDAQ
--
--(--)
--
--(--)
7.12 / 10
Outperform
Analyst coverage is limited to a single neutral rating, while the stock has slipped 7.38% recently. Fund‑flow metrics are strong (7.66/10) with small and large investors net buying, though overall and block trends are negative, indicating mixed capital sentiment.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-06
InstitutionPiper Sandler
Times predicted2
Historical Win Rate100.0%
What is the analyst consensus for TVTX?
- TVTX holds a Bullish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.12/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
